Evidence map›Paper›PMID 28954551›Full record

ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2018

Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.

Scott M Thompson, Danielle E Jondal, Kim A Butters, Bruce E Knudsen, Jill L Anderson, Matthew P Stokes, Xiaoying Jia, Joseph P Grande, Lewis R Roberts, Matthew R Callstrom and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Scott M Thompsona Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Danielle E Jondala Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Kim A Buttersa Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Bruce E Knudsena Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Jill L Andersona Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Matthew P Stokesb Cell Signaling Technology, Inc. 3 Trask Ln. Danvers , MA , USA.
Xiaoying Jiab Cell Signaling Technology, Inc. 3 Trask Ln. Danvers , MA , USA.
Joseph P Grandec Department of Laboratory Medicine and Pathology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Lewis R Robertsd Division of Gastroenterology and Hepatology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Matthew R Callstroma Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
David A Woodruma Department of Radiology , Mayo Clinic School of Medicine , Rochester , MN , USA.
Mayo Clinic in Arizona · USCell Signaling Technology (United States) · US

Funding

Mayo Clinic Center for Translational Science ActivitiesTL1RR024152 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$2.5M
EXTRAMURAL RES FACIL IMPROVEMENT PROG: POLYCYSTIC KIDNEY DISEASE, RENAL STUDIES,C06RR018898 · NCRR · MAYO CLINIC · PI BURNETT, JOHN C · 2004 to 2004
$2.3M
Mayo Clinic Center for Translational Science ActivitiesTL1TR000137 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$2.1M
Regulation of molecular thermal ablative resistance in hepatocellular carcinomaR01CA177686 · NCI · MAYO CLINIC ROCHESTER · PI WOODRUM, DAVID A · 2013 to 2017
$1.6M
NCATS NIH HHS TL1 TR000137NCI NIH HHS R01 CA177686NCRR NIH HHS C06 RR018898NCRR NIH HHS TL1 RR024152
6 · The paper itself

Abstract

purposeThe aims of the present study were 2-fold: first, to test the hypothesis that heat stress induces MET and EGFR signalling in hepatocellular carcinoma (HCC) cells and inhibition of this signalling decreases HCC clonogenic survival; and second, to identify signalling pathways associated with heat stress induced MET signalling. MATERIALS AND

methodsMET

resultsHeat-stress induced rapid MET and EGFR phosphorylation that is distinct from HGF or EGF in HCC cells and thermal ablation induced MET but not EGFR phosphorylation at the HCC tumour ablation margin. Inhibition of the MET and EGFR blocked both heat stress and growth factor induced MET and EGFR phosphorylation and inhibition of MET decreased HCC clonogenic survival following heat stress. Pathway analysis of quantitative phosphoproteomic data identified downstream pathways associated with heat stress induced MET signalling including AKT, ERK, Stat3 and JNK. However, inhibition of heat stress induced MET signalling did not block AKT signalling.

conclusionsHeat-stress induced MET and EGFR signalling is distinct from growth factor mediated signalling in HCC cells and MET inhibition enhances heat stress induced HCC cell killing via a PI3K/AKT/mTOR-independent mechanism.

Indexed as

Heat-Shock ResponseCarcinoma, HepatocellularErbB ReceptorsHumansLiver NeoplasmsSignal TransductionEGFR protein, humanErbB ReceptorsAKTEGFRheat stresshepatocellular carcinomaMETthermal ablation

Identifiers

PMID28954551
PMCPMC6175538
OpenAlexW2759725731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.